| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |